Snanoudj R, Marquant F, Renaudin K, Dubois V, et al. Bortezomib in combination with standard-of-care for late active antibody-mediated rejection with de novo donor-specific antibodies after kidney transplantation: a multicenter randomized trial. Transpl Int 2026;39:16702.
PMID: 42846119